KINGDON CAPITAL
Kingdon Capital Management, L.L.C. is an employee owned hedge fund sponsor. The firm provides its services to high net worth individuals and institutional clients. It invests in the public equity, fixed income, and alternative investment markets across the globe. The firm invests in growth and value stocks of all-cap companies. It also invests in currency futures and options and long/short strategies to hedge its client's risks. It employs a top-down approach to select the economies and fundamental and technical analysis with a bottom-up stock picking approach to make investments. The firm conducts in-house research to make its investments. Kingdon Capital Management was founded in 1983 and is based in New York City.
KINGDON CAPITAL
Founded:
1983-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Domain Not Resolving Apache Wordpress Plugins PHP
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-31 | Sapience Therapeutics | Kingdon Capital investment in Series B - Sapience Therapeutics | 41 M USD |
| 2021-11-02 | Shoreline Biosciences | Kingdon Capital investment in Series B - Shoreline Biosciences | 140 M USD |
| 2021-09-27 | Jasper Therapeutics | Kingdon Capital investment in Post-IPO Equity - Jasper Therapeutics | 100 M USD |
| 2021-04-13 | CeQur | Kingdon Capital investment in Series C - CeQur | 115 M USD |
| 2020-11-19 | Imago BioSciences | Kingdon Capital investment in Series C - Imago BioSciences | 80 M USD |
| 2019-12-05 | Athenex | Kingdon Capital investment in Post-IPO Equity - Athenex | 60 M USD |
| 2018-06-18 | Stealth BioTherapeutics | Kingdon Capital investment in Convertible Note - Stealth BioTherapeutics | 100 M USD |
| 2017-04-23 | SteadyMed Therapeutics | Kingdon Capital investment in Post-IPO Equity - SteadyMed Therapeutics | 30 M USD |
| 2017-01-03 | Napo Pharmaceuticals | Kingdon Capital investment in Debt Financing - Napo Pharmaceuticals | 2 M USD |
| 2007-05-25 | Mformation Technologies | Kingdon Capital investment in Series E - Mformation Technologies | 20 M USD |